The headline story on opioid use by beneficiaries in the US Medicare Part D program is shifting for the first time in five years from an emphasis on abuse and over-prescribing to positive trends towards a sustained decrease in overall opioid use accompanied by a continued upswing in the medication-assisted treatment drugs.
In a now-annual analysis of the trends for opioids in Part D, the Department of Health & Human Services’ Office...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?